Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
Matafonov A, Leung PY, Gailani AE, Grach SL, Puy C, Cheng Q, Sun MF, McCarty OJ, Tucker EI, Kataoka H, Renné T, Morrissey JH, Gruber A, Gailani D. Matafonov A, et al. Among authors: gailani d, gailani ae. Blood. 2014 Mar 13;123(11):1739-46. doi: 10.1182/blood-2013-04-499111. Epub 2014 Jan 9. Blood. 2014. PMID: 24408325 Free PMC article.
Factor XI as a target for antithrombotic therapy.
Bane CE Jr, Gailani D. Bane CE Jr, et al. Among authors: gailani d. Drug Discov Today. 2014 Sep;19(9):1454-8. doi: 10.1016/j.drudis.2014.05.018. Epub 2014 Jun 2. Drug Discov Today. 2014. PMID: 24886766 Free PMC article. Review.
Factor XI antisense oligonucleotide for prevention of venous thrombosis.
Büller HR, Bethune C, Bhanot S, Gailani D, Monia BP, Raskob GE, Segers A, Verhamme P, Weitz JI; FXI-ASO TKA Investigators. Büller HR, et al. Among authors: gailani d. N Engl J Med. 2015 Jan 15;372(3):232-40. doi: 10.1056/NEJMoa1405760. Epub 2014 Dec 7. N Engl J Med. 2015. PMID: 25482425 Free PMC article. Clinical Trial.
Future prospects for contact factors as therapeutic targets.
Gailani D. Gailani D. Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):52-9. doi: 10.1182/asheducation-2014.1.52. Epub 2014 Nov 18. Hematology Am Soc Hematol Educ Program. 2014. PMID: 25696834 Free PMC article. Review.
Factor XI antisense oligonucleotide for venous thrombosis.
Büller HR, Gailani D, Weitz JI. Büller HR, et al. Among authors: gailani d. N Engl J Med. 2015 Apr 23;372(17):1672. doi: 10.1056/NEJMc1503223. N Engl J Med. 2015. PMID: 25901434 No abstract available.
Theme 3: Non-invasive management of (recurrent) venous thromboembolism (VTE) and post thrombotic syndrome (PTS).
ten Cate-Hoek AJ, Weitz JI, Gailani D, Meijer K, Philippou H, Bouman AC, Whitney Cheung Y, van Mens TE, Govers-Riemslag JW, Vries M, Bleker S, Biedermann JS, Stoof SC, Buller HR. ten Cate-Hoek AJ, et al. Among authors: gailani d. Thromb Res. 2015 Sep;136 Suppl 1(Suppl 1):S13-8. doi: 10.1016/j.thromres.2015.07.036. Thromb Res. 2015. PMID: 26387731 Free PMC article. No abstract available.
Factor XI as a Therapeutic Target.
Gailani D, Gruber A. Gailani D, et al. Arterioscler Thromb Vasc Biol. 2016 Jul;36(7):1316-22. doi: 10.1161/ATVBAHA.116.306925. Epub 2016 May 12. Arterioscler Thromb Vasc Biol. 2016. PMID: 27174099 Free PMC article. Review.
Why factor XI deficiency is a clinical concern.
Wheeler AP, Gailani D. Wheeler AP, et al. Among authors: gailani d. Expert Rev Hematol. 2016 Jul;9(7):629-37. doi: 10.1080/17474086.2016.1191944. Epub 2016 Jun 24. Expert Rev Hematol. 2016. PMID: 27216469 Free PMC article. Review.
214 results